Current directions in co-crystal growth

被引：139

作者：

Blagden, Nicholas ^{[1
,2
]}

Berry, David J. ^{[1
,2
]}

Parkin, Andrew ^{[3
]}

Javed, Hafsa ^{[1
,2
]}

Ibrahim, Asim ^{[1
,2
]}

Gavan, Pauline T. ^{[1
,2
]}

De Matos, Luciana L. ^{[1
,2
]}

Seaton, Colin C. ^{[1
,2
]}

机构：

[1] Univ Bradford, Inst Pharmaceut Innovat, Solid State Pharmaceut Grp, Bradford BD7 1DP, W Yorkshire, England

[2] Univ Bradford, Bradford Sch Pharm, Bradford BD7 1DP, W Yorkshire, England

[3] Univ Glasgow, Dept Chem, WestCHEM, Glasgow G12 8QQ, Lanark, Scotland

来源：

NEW JOURNAL OF CHEMISTRY | 2008年 / 32卷 / 10期

基金：

英国工程与自然科学研究理事会;

关键词：

D O I：

10.1039/b803866j

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

In this feature article we will focus on the issues relating to the crystal growth of co-crystals, with a particular emphasis on drug development. The initial focus of this perspective is on the relevant literature examples that may be able to inform our understanding with regards co-crystal crystallisation and the allied supramolecular concepts. The second part of this perspective contains selected examples from our own work, which add to the literature perspective. Topics include; nucleation templates, in situ synchrotron XRD studies, solid-state synthesis through mixing and screening strategies.

引用

页码：1659 / 1672

页数：14

共 111 条

[1]

AAKEROY CB, 1998, CRYSTAL ENG, V0001

[2] Do polymorphic compounds make good cocrystallizing agents?: A structural case study that demonstrates the importance of synthon flexibility [J].

Aakeröy, CB ;

Beatty, AM ;

Helfrich, BA ;

Nieuwenhuyzen, M .

CRYSTAL GROWTH & DESIGN, 2003, 3 (02) :159-165

[3] Crystal engineering: Strategies and architectures [J].

Aakeroy, CB .

ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1997, 53 :569-586

[4] Polymorphs of a 1:1 cocrystal with tunnel and layer structures:: pp′-biphenol/dimethyl sulfoxide [J].

Ahn, S ;

Kariuki, BM ;

Harris, KDM .

CRYSTAL GROWTH & DESIGN, 2001, 1 (02) :107-111

[5] The Cambridge Structural Database: a quarter of a million crystal structures and rising [J].

Allen, FH .

ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 2002, 58 (3 PART 1) :380-388

[6] Crystal engineering of the composition of pharmaceutical phases.: Do pharmaceutical co-crystals represent a new path to improved medicines? [J].

Almarsson, Ö ;

Zaworotko, MJ .

CHEMICAL COMMUNICATIONS, 2004, (17) :1889-1896

[7] Comment on "On the presence of multiple molecules in the crystal asymmetric unit (Z′ > 1)'' by Gautam R.!Desiraju, CrystEngComm, 2007, 9, 91 [J].

Anderson, Kirsty M. ;

Steed, Jonathan W. .

CRYSTENGCOMM, 2007, 9 (04) :328-330

[8]

[Anonymous], GRAS NOTICES

[9]

ATTWOOD D, 1983, SURFACTANT SYSTEMS T, P370

[10] The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics [J].

Bak, Annette ;

Gore, Anu ;

Yanez, Evelyn ;

Stanton, Mary ;

Tufekcic, Sunita ;

Syed, Rashid ;

Akrami, Anna ;

Rose, Mark ;

Surapaneni, Sekhar ;

Bostick, Tracy ;

King, Anthony ;

Neervannan, Sesha ;

Ostovic, Drazen ;

Koparkar, Arun .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (09) :3942-3956

← 1 2 3 4 5 6 7 8 9 10 →